Genesis HealthCare (GEN) Reports In-Line Q1 EPS, provides guidance

Genesis HealthCare (NASDAQ: GEN) reported Q1 EPS of $0.53, in-line with the analyst estimate of $0.53. Revenue for the quarter came in at $965 million versus the consensus estimate of $965.44 million.

GUIDANCE:

Genesis HealthCare sees Q2 2025 EPS of $0.53-$0.55, versus the consensus of $0.54. Genesis HealthCare sees Q2 2025 revenue of $965-975 million, versus the consensus of $968.3 million.

Re-affirm Fiscal Year 2025 Non-GAAP Annual Guidance

Revenue expected to be in the range of $3,890 to $3,930 million, versus the consensus of $3.91 billion.
EPS expected to be in the range of $2.17 to $2.23, versus the consensus of $2.20.

For earnings history and earnings-related data on Genesis HealthCare (GEN) click here.

You May Also Be Interested In

• Occidental Petroleum releases Q2 2026 earnings considerations
• Apple suing OpenAI over alleged misappropriation of trade secrets
• Baird on Nurix (NRIX) Earnings Amid 7% Drop: '2Q Print Solid as Breadth of Development Expands'